VENTRIA BIOSCIENCE
Ventria Bioscience is a privately held biopharmaceutical company with a product pipeline enabled by ExpressTec. ExpressTec is a patented, plant-based recombinant protein manufacturing technology that delivers a ten-fold higher recombinant protein yield than other plant-based systems. Ventria Bioscience's platform technology delivers meaningful and sustainable economic advantages by enabling new product opportunities that were not previously available. It can be used to develop new biotherapeutics, novel vaccines, reagents for biomanufacturing, and industrial and biofuel enzymes.
VENTRIA BIOSCIENCE
Industry:
Biotechnology Health Care Manufacturing Pharmaceutical
Founded:
1993-01-01
Address:
Junction City, Kansas, United States
Country:
United States
Website Url:
http://www.ventria.com
Total Employee:
11+
Status:
Active
Contact:
(970)407-1239
Email Addresses:
[email protected]
Total Funding:
7.67 M USD
Technology used in webpage:
SPF Amazon Person Schema Microsoft Exchange Online Office 365 Mail Gravatar Profiles Google Apps For Business Microsoft Azure DNS GoDaddy DNS AWS Global Accelerator
Similar Organizations
Achieve Life Science
Achieve Life Science is a privately-held specialty pharmaceutical provider.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Janssen
Janssen is the pharmaceutical arm of Johnson & Johnson.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Obexia
Obexia is a privately held biopharmaceuticals start-up company based in Basel.
Pharmaceutic Litho & Label
A Pharmaceutical Printer & Pharmaceutical Label Company
Tiancheng Yaoye
Tiancheng Yaoye is a licorice extract production company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Ventria Bioscience
Official Site Inspections
http://www.ventria.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ventria Bioscience"
Ventria Bioscience - Crunchbase Company Profile
Ventria Bioscience is a privately held biopharmaceutical company with a product pipeline enabled by ExpressTec. ExpressTec is a patented, plant-based …See details»
Ventria Bioscience - Wikipedia
Ventria Bioscience is a biotech company with a focus on human nutrition and human therapeutics. The company was established in 1993 in Colorado. The company's core technology is a genetically modified crop-based protein production system (also called a "pharming" system or 'biopharming' ) called ExpressTec. They have also made applications to grow rice with human genes. See details»
Ventria Bioscience - VentureRadar
Ventria Bioscience is a privately held biopharmaceutical company whose vision is to improve human longevity and quality of life by developing and commercializing innovative medicines …See details»
Ventria Bioscience Company Profile 2024: Valuation, …
Information on acquisition, funding, cap tables, investors, and executives for Ventria Bioscience. Use the PitchBook Platform to explore the full profile. …See details»
Ventria Biosciences (formerly known as Applied …
Ventria Bioscience's platform technology delivers meaningful and sustainable economic advantages by enabling new product opportunities that were not previously available. It can be used to develop new biotherapeutics, novel …See details»
Ventria Bioscience Company Profile - Office Locations ... - Craft
Ventria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases. It produces medicinal products that are enabled by ExpressTec, a …See details»
Ventria Bioscience - Devex
Ventria Bioscience is a privately held biopharmaceutical company with a product pipeline enabled by ExpressTec. ExpressTec is a patented, plant-based recombinant protein manufacturing …See details»
Ventria Bioscience Plans to Double Biomanufacturing Capacity
Sep 8, 2017 · Ventria’s proprietary ExpressTec platform for biomanufacturing produces biological products known for purity, safety and cost-effectiveness. Ventria is developing a promising …See details»
Ventia | ASX & NZX: VNT
Ventia brings more than 65 years' knowledge, understanding and experience in providing essential services to the Australian and New Zealand markets. We put safety first, build trust in our communities, deliver for our clients, champion …See details»
Ventria Bioscience - Company Profile and News - Bloomberg …
Ventria Bioscience develops, manufactures, and markets health and nutrition products. The Company offers lactoferrin and lysozyme glycoproteins, which are used for gastrointestinal …See details»
Ventria Bioscience - jcgced.com
Ventria Bioscience is a privately held biopharmaceutical company whose vision is to improve human longevity and quality of life by developing and commercializing innovative medicines and cell-culture media components derived from …See details»
Ventria Bioscience Announces Expansion of Biomanufacturing and ...
Ventria is developing a promising pipeline of novel therapeutic proteins for potential treatment of human diseases. In addition, Ventria manufactures high-quality, defined, animal-free reagents …See details»
Ventria Bioscience Wins Exclusion Order Against Infringing and ...
Sep 14, 2022 · Ventria Bioscience is a privately held biotechnology company whose vision is to improve human longevity and quality of life by developing and commercializing innovative …See details»
InVitria Announces New Media Formulation Service
Leveraging Ventria’s proprietary ExpressTec technology, InVitria has developed and commercialized eight recombinant proteins and cell culture media supplements made in a …See details»
Ventria Continues Partnership With The Chase Group to Find …
Jul 27, 2021 · Ventria Bioscience has partnered once again with The Chase Group to continue building their leadership team as they develop and commercialize innovative medicines with …See details»
Center for Food Safety | Press Releases | | USDA Approves …
Jun 30, 2005 · The U.S. Department of Agriculture has quietly approved controversial proposals by genetic engineering firm Ventria Biosciences to grow rice containing human genes on 270 …See details»
PharmaceuticalRice in California
Ventria Bioscience or its predecessor Applied Phytologics has been conducting outdoor field tri-als of genetically engineered, pharmaceutical-producing rice in California’s Central Valley since...See details»
Center for Food Safety | Press Releases | | VENTRIA BIOSCIENCE …
Apr 9, 2008 · Ventria Bioscience, the California-based developer of genetically engineered pharmaceutical rice, faces new and daunting challenges in efforts to market its “pharma rice” …See details»
InVitria: Recombinant, Animal-Free Cell Culture Media
InVitria develops and manufactures recombinant proteins for high-performing, chemically defined biomanufacturing and final formulation. Our products are incorporated in 30 on-market …See details»
ExpressTec Recombinant Proteins – ExpressTec Proteins: Pure, …
ExpressTec is unlike standard bacterial, yeast, and mammalian cell-culture expression systems, transgenic animals, or purification from natural sources. Commercial-scale product yields in a …See details»